# Mesoblast Limited (MEOBF)

> Healthcare · AU · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MEOBF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 51.34M | $ -40.16M | $ -35.41M | $ 135.14M | $ 574.68M |
| 2025 | $ 17.61M | $ -104.58M | $ -52.09M | $ 128.16M | $ 597.44M |
| 2024 | $ 6.20M | $ -92.45M | $ -29.28M | $ 118.92M | $ 480.36M |
| 2023 | $ 8.11M | $ -88.54M | $ -68.75M | $ 116.50M | $ 501.84M |
| 2022 | $ 11.41M | $ -102.04M | $ -73.74M | $ 106.91M | $ 497.04M |
| 2021 | $ 8.84M | $ -117.45M | $ -56.71M | $ 105.50M | $ 581.40M |
| 2020 | $ 40.27M | $ -99.29M | $ -74.67M | $ 99.31M | $ 549.33M |
| 2019 | $ 21.59M | $ -115.91M | $ -74.95M | $ 81.29M | $ 481.05M |
| 2018 | $ 22.65M | $ -46.61M | $ -99.33M | $ 59.40M | $ 546.01M |
| 2017 | $ 3.25M | $ -103.48M | $ -129.04M | $ 0 | $ 516.77M |
| 2016 | $ 58.54M | $ -5.68M | $ -122.34M | $ 0 | $ 528.16M |
| 2015 | $ 33.34M | $ -167.60M | $ -166.29M | $ 0 | $ 609.36M |
| 2014 | $ 32.64M | $ -105.67M | $ -106.76M | $ 0 | $ 571.72M |
| 2013 | $ 49.54M | $ -88.15M | $ -79.14M | $ 0 | $ 630.27M |
| 2012 | N/A | N/A | N/A | $ 0 | $ 478.85M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.24 |
| Liabilities / Eq | 0.36 |
| Current Ratio | 1.58 |

## Other views

- [Metrics](https://sponda.capital/en/MEOBF.md)
- [Charts](https://sponda.capital/en/MEOBF/charts.md)
- [Compare](https://sponda.capital/en/MEOBF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.